(Q35633250)

English

Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index

scientific article published on 18 January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

anti-retroviral agent

0 references

object named as

Robert S Hogg

8

0 references

author name string

David M Moore

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Anna Awor

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Robert S Downing

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Willy Were

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Peter Solberg

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

David Tu

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Keith Chan

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Jonathan Mermin

9

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

18 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

AIDS Research and Therapy

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

https://scigraph.springernature.com/pub.10.1186/1742-6405-4-1

0 references

Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796890

27 July 2018

Use of total lymphocyte count for monitoring response to antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796890

27 July 2018

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796890

27 July 2018

Confidence intervals for a binomial proportion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796890

27 July 2018

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796890

25 September 2018

Application of an algorithm to predict CD4 lymphocyte count below 200 cells/mm(3) in HIV-infected patients in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796890

25 September 2018

Indirect markers to initiate highly active antiretroviral therapy in a rural African setting.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796890

25 September 2018

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796890

25 September 2018

Absolute or total lymphocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796890

25 September 2018

The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796890

25 September 2018

CD4 and total lymphocyte counts as predictors of HIV disease progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796890

25 September 2018

Predicting CD4 counts in HIV-infected Brazilian individuals: a model based on the World Health Organization staging system

1 reference

https://pubmed.ncbi.nlm.nih.gov/17233896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17233896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/17233896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings

1 reference

https://pubmed.ncbi.nlm.nih.gov/17233896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings

1 reference

https://pubmed.ncbi.nlm.nih.gov/17233896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings

1 reference

https://pubmed.ncbi.nlm.nih.gov/17233896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1742-6405-4-1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35633250&oldid=1861936588"